$LIVN SEC Filings

Filed On	Filing
16 Sep 2026	Form 4: Liddy Anne M., Chief Legal Officer Granted 6,291 Restricted Stock Units
14 Sep 2026	Form 4: Bianchi Francesco, Director Sold 3,500 shares ($273K)
10 Sep 2026	144
08 Sep 2026	Form 4: Story Brooke, Director Sold 2,300 shares ($187K)
04 Sep 2026	144
02 Sep 2026	144
02 Sep 2026	Form 4: Bianchi Francesco, Director Sold 1,650 shares ($132K)
02 Sep 2026	Form 3: Liddy Anne M., Chief Legal Officer No securities owned
31 Aug 2026	144
13 Aug 2026	Form 4: Tezel Ahmet, Chief Innovation Officer Received 12,692 shares by exercise or conversion ($669K) · Returned 8,589 shares to the issuer ($669K) · Gave up 1,428 shares to cover exercise price or tax ($111K) · 1 more
11 Aug 2026	144
06 Aug 2026	SCHEDULE 13G
05 Aug 2026	IRANNOTICE
05 Aug 2026	10-Q
05 Aug 2026	Form 3: Folli Stefano, President, Cardiopulmonary
05 Aug 2026	8-K: Results of Operations and Financial Condition
17 Jun 2026	Form 4: Wilver Peter M, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Schermerhorn Todd C, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units
17 Jun 2026	Form 4: Bianchi Francesco, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Sold 1,200 shares ($96.2K) · 1 more
17 Jun 2026	Form 4: Podlogar Susan M, Director Received 4,042 shares by exercise or conversion · Gave up 486 shares to cover exercise price or tax ($38.7K) · Granted 2,383 Restricted Stock Units

Comments